Cancer Immunity Cycle Could Inform Development of Novel Immu

Further understanding of the cancer immunity cycle could drive the development of novel immune therapies for patients with renal cell carcinoma.

Related Keywords

United States , America , Michaelb Atkins , Vivek Narayan , Eric Jonasch , Katy Beckermann , International Kidney Cancer Symposium , Hospital Of The University Pennsylvania , Novel Therapy Development , Kidney Cancer Symposium , Immunity Cycle , Cancer Immunity Cycle , Immune Therapies , Early Phase Clinical Development , North America , Conventional Immune Checkpoint Inhibition , Renal Cell Carcinoma , Solid Tumor , Nat Rev Clin , Immune Therapy , Nrcc ,